Sanofi
SNYNF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $95,262 | $99,451 | $125,803 | $114,742 |
| - Cash | $8,906 | $15,359 | $7,991 | $7,441 |
| + Debt | $21,755 | $22,285 | $21,047 | $17,906 |
| Enterprise Value | $108,111 | $106,377 | $138,859 | $125,207 |
| Revenue | $13,170 | $10,735 | $10,606 | $11,420 |
| % Growth | 22.7% | 1.2% | -7.1% | – |
| Gross Profit | $9,758 | $7,743 | $7,717 | $7,844 |
| % Margin | 74.1% | 72.1% | 72.8% | 68.7% |
| EBITDA | $4,214 | $1,889 | $2,770 | $563 |
| % Margin | 32% | 17.6% | 26.1% | 4.9% |
| Net Income | $2,802 | $3,940 | $1,872 | $683 |
| % Margin | 21.3% | 36.7% | 17.7% | 6% |
| EPS Diluted | 2.27 | 3.19 | 1.52 | 0.4 |
| % Growth | -28.8% | 109.9% | 280% | – |
| Operating Cash Flow | – | $0 | $2,093 | $0 |
| Capital Expenditures | – | $0 | $0 | $0 |
| Free Cash Flow | – | $0 | $2,093 | $0 |